Crystal structure of bis(p-phenoxyphenyl) tellurium dichloride

Crystals of (p-PhOC₆H₄)₂TeCl₂ are monoclinic with space groupP2₁/c,a=8.063(2),b=21.695(5),c=12.622(2) Å,=101.57(2)°, andZ=4. The structure refined to a finalR value of 0.055 for 2135 unique observed reflections. The compound adopts a primary four-coordinate geometry based on a distorted trigonal bipyramid with an equatorial lone pair. A weak Te-Cl secondary interaction links the molecules into centrosymmetric dimers.     

Complexation with diol host compounds. Part 2. Structures of 1,1,2,2-tetraphenylethane-1,2-diol and its 1∶2 molecular inclusion complex with dimethylsulphoxide

The structures of 1,1,2,2-tetraphenylethane-1,2-diol and its 12 molecular inclusion complex with dmso have been elucidated by X-ray crystallography from single crystal diffraction data. Crystals of the host, compound I, are monoclinic, space groupP2₁/n, witha=17.669(6) Å,b=6.144(6) Å,c=17.873(6) Å,=92.67(3)°,z=4. Crystals of the clathrate, compound II, are triclinic,P¯1, witha=9.138(5) Å,b=18.384(6) Å,c=18.496(3) Å,=61.16(2)°,=83.22(3)°, =88.06(3)°,Z=4. Both structures were solved by direct methods and refined to finalR values of 0.072 and 0.107, respectively. Compound I is partially disordered and its packing is governed by strong intermolecular hydrogen bonds. Compound II is characterized by crossing channels which accommodate the guest dmso molecules. The thermal properties of the latter compound have been characterized by DTA and TGA thermograms.     

Crystal and molecular structure of 2′,2′,4,4,5′,5′,6,6-octamethyl-2′,4,5′,6-tetrahydrofuro[3,4-d]-1, 3-oxathiol-2-spiro-3′-furan-4′-(3′H)-one

Crystals of the title compound are monoclinic,a = 13.966(4),b = 9.141(3),c= 15.901(6) Å, =123.0(7) °,Z = 4. The structure was established by direct methods based on 2827 reflections, using MoK radiation, refined to an ultimate coventionalR of 0.081. The furanone ring is closely similar to that found in a related spiro-connected molecule in this series.     

Crystal and molecular structure of 0,0,0-propan-1,2,3-trithionobenzoate (3TBZ): Implication for thermally induced solid-state transformation of 3TBZ

The crystal and molecular structure of 0,0,0-propan-1,2,3-trithiobenzoate (3TBZ) has been determined by direct methods. Crystals are monoclinic,a=6.810(2),b=35.950(2),c=9.415(2) Å,=94.78(2)°, space group P2₁/c,Z=4. The structure was refined using full-matrix least-squares toR=0.078,R _w=0.064, 1957 reflections CuK radiation, =1.5418 Å. The molecule has one relatively short S---C (methylene) intramolecular distance, S(2)---C(38)=3.440(4)Å, approximately 1.5 Å less than the shortest S---C distance observed in related crystal structures. An hypothesis related to this short contact is proposed in order to account for the unusual pyrolitic behavior of this compound in the solid state.     

Crystal structure of 1,1-diphenyl-2,4-dimethyl-5-(N-benzamide)-1,3-pentadiene

Crystals of the title compound are monoclinic (C₂₆H₂₅NO): space groupP2₁/c,a=16.565(3),b=10.328(2),c=12.621(3) Å,=104.02(3)°. The structure was solved by direct methods and refined by block-matrix least-squares to giveR=0.056 andR _w =0.061 for 1613 reflections above 2(I). The amide moiety is tilted by 19.3(2)° with respect to the mean aromatic ring plane. The two othergem phenyl rings subtend a dihedral angle of 112.2(4)° to each other. The molecules are joined in the solid by N-HO hydrogen bonds.     

Crystal structure of (E)-5-hydroxypyrrolizidin-3-one and (Z)-5-thioketalpyrrolizidin-3-one

The crystal structures of (E)-5-hydroxypyrrolizidin-3-one (2) and (Z)-5-thioketalpyrrolizidin-3-one (3) have been determined by single-crystal x-ray diffraction techniques and refined by full-matrix least squares. Molecule2 crystallizes in the monoclinic space groupP2₁/a(No. 14) witha=7.887(3) Å,b=9.788(5) Å,c=9.316(4) Å,=100.6(1), andZ=4. Molecule 3 crystallizes in the monoclinic space groupP2₁/c witha=12.947(14) Å,b=10.553(14) Å,c=9.629(14) Å,=101.4(1), andZ=4. The calculated density for both molecules is 1.33 g cm^–1. FinalR-factors were 5.1% for2 and 8.59% for3. The x-ray results showed that a change in configuration occurred in the reaction going from2 to3.     

Crystal and molecular structures of the 4-(1H)-pyridone (=L) lanthanide complexes {[GdL(NO3)3(H2O)]·CH3OH}2 and [DyL4(NO3)2](NO3) and of L2HNO3

The crystal structures of the title compounds have been determined by single crystal diffraction methods. Crystals of the dysprosium compound are monoclinic, space groupP2₁/c witha=14.133(4),b=13.438(5),c=14.401 (4)Å,=103.98(2)°,V=2654(1)ų,Z=4,D _c =1.82 g cm^–3, finalR=0.035. The Dy atom is eight-coordinate with a distorted dodecahedral coordination geometry involving two bidentate nitrate groups and four pyridone oxygen atoms. An erbium complex with analogous stoichiometry was also prepared but not structurally characterized. Crystals of the Gd compound are monoclinic, space groupP2₁/n, witha=11.226(2),b=9.075(2),c=16.737(3)Å,=93.88(3)°,V=1701(1)ų,Z=2,D _c =1.91 g cm^–3, finalR=0.042. Each Gd atom is bonded to one pyridone oxygen atom, a water molecule and three bidentate nitrate groups. An oxygen atom of one of the bidentate nitrates additionally serves to bridge pairs of Gd atoms so as to form a dinuclear complex in which each Gd atom is nine-coordinate with a tricapped trigonal prismatic geometry. Crystals of L₂HNO₃ are monoclinic, space groupI2/a witha=12.479(4),b=6.535(2),c=14.297(6)Å,=96.07(3)°,V=1159(1)ų,Z=4,D _c =1.45 g cm^–3, finalR=0.057. The pyridones are linked in pairs by very short (2.44 Å) symmetrical OHO hydrogen bonds. Each pair is further linked via a nitrate ion by means of N-HO(nitrate)H-N hydrogen bonds, so as to form an extended chevron-like pyridone-pyridone-nitrate-pyridone-pyridone array. Adjacent chains are linked via weak C-HO(NO₃) interactions.     

Crystal and molecular structure of 6-phenyl-13H-pyrimido [4,3-b:6,1-b] bis-benzothiazolium-12 triiodide

Crystals of the synthesized title compound (C₂₂H₁₅I₃N₂) are monoclinic. Space group P2₁/a,a=15.072(2),b=10.936(1),c=15.363(2) Å,=108.49(1)°. The structure was solved by direct methods and refined by block-matrix least-squares procedure to giveR=0.059 and Rw=0.043 for 3658 reflections above 2(I). The central hexaatomic ring is in a very flattened envelope conformation being the methylene group very little deviated from the plane defined by the other five atoms. The phenyl group is rotated 63.40° from that plane.     

Crystal structures ofN(6)-methyladenine hydrochloride andN(6),N(9)-dimethyladenine

The crystal structures ofN (6)-methyladenine hydrochloride (6-MA·HCl) and ofN (6),N (9)-dimethyladenine (6,9-DMA) were determined by the use of X-ray diffractometer data. Crystals of 6-MA·HCl are monoclinic, space groupP2₁/m, witha = 9.3450(6),b = 6.5838(4),c = 7.3142(3) Å, = 114.837(4) °, andZ = 2. Crystals of 6,9-DMA are monoclinic, space groupP2₁/c, witha = 12.045(3),b = 6.135(2),c = 23.27(1) Å, = 111.79(3), andZ = 8. The crystal structures were refined by least-squares toR = 0.053 for 6-MA·HCl andR = 0.071 for 6,9-DMA. The N(1)-protonated adenine derivative in the 6-MA·HCl crystal structure and the two crystallographically independent adenine derivatives in the 6,9-DMA structure all assume conformations in which the methyl substituent at N(6) is in or near the purine plane, and is pointing away from the imidazole moiety.     

Crystal and molecular structure analysis of benzamide neuroleptics and analogs (VIII):endo- andexo-2,3-dimethoxy-N-[8-(phenylmethyl)-8-azabicyclo[3.2.1]oct-2-y1]-benzamide hydrochloride: C23H28N2O3·HCl

The crystal structures ofendo- andexo-2,3-dimethoxy-N-[8(phenylmethyl)-8-azabicyclo[3.2.1]oct-2-y1]benzamide hydrochloride have been determined by single-crystal X-ray diffraction techniques, and refined by full-matrix least squares. The endo-compound crystallizes in the monoclinic space groupP2₁/n witha=12.389(2) Å,b=22.861(3) Å,c=8.019(2) Å,=93.58(2)°, andZ=4; the exo-compound crystallizes in the monoclinic space groupP2₁/a witha=26.295(12) Å,b=12.503(4) Å,c=6.667(7) Å,=97.80(6)°, andZ=4. The calculated densities are 1.22 and 1.27 g cm^–3 respectively. FinalR-factors are 0.04 for the endo and 0.05 for the exo-compound. Comparison with a very active analog, the tropapride, suggests that the lack of antipsychotic activity is due to a different orientation of the dimethoxyphenyl or carbonyl group for the exo- and endo-compound, respectively.     

Refinements of the crystal structures of 1,4-diphenylbutadiyne and its complex with two moles of Co2(CO)6

1,4-diphenylbutadiyne, C₁₆H₁₀, crystallizes in monoclinic space group P2₁/n witha=6.6152(6),b=6.0768(7),c=14.634(1) Å, =100.981(8)⁰,V=577.5(2) ų,Z=2. The structure was refined toR=0.077 andR _w=0.069 for 1007 observed reflections with CuK radiation. The molecule lies on an inversion center. Our determination represents and increase in precision of a factor of approximately three over the original determination. The 21 cobalt complex, C₁₆H₁₀[Co₂(CO)₆]₂, also crystallizes in monoclinic space group P2₁/n witha=8.9568(12),b=17.7057(10),c=18.5671(12) Å, =90.606(12)^o,V=2944.3(5) ų,Z=4. The structure was refined toR=0.032 andR _w=0.031 for 4312 observed reflections. The diphenylbutadiyne triple bonds elongate to 1.346(3) Å and the angles at the diyne C atoms decrease to 134.1(3)–144.9(3)^o upon complexation. The Co-Co distance is 2.4580(4)Å. Our data represent an increase in precision by a factor of 2–3 over the original determination.     

Crystal structure of [bis 1,2-(diphenylphosphino)ethane]-bis(pyridine-2-thiolato)ruthenium(II)

The Ru atom in the title compound, [Ru(dppe)(2-pyS)₂] exists in a distorted octahedral geometry defined by a dppe ligand and two 2-pyS anions which function as bidentate ligands via their N- and S-atoms. Important interatomic parameters are Ru-P2.240(3), 2.256(3); Ru-N 2.131(8), 2.136(8); Ru-S 2.413(3), 2.428(3) Å; P-Ru-P 84.1(1), S-Ru-S 155.0(1) and N-Ru-N 87.5(3)°. Crystals are monoclinic, space groupP2₁/c, with unit cell dimensionsa=10.342(1),b=31.145(6),c=11.107(2) Å,=113.80(1)° andZ=4. The structure was refined to finalR=0.064 for 3057 reflections withI2.5(I).     

Preparation,spectral studies and X-ray crystal structure of 1,3,5-triphenyl-1,5-pentanedione,C23H20O2

1,3,5-triphenyl-1,5-pentanedione, C₂₃H₂₀O₂, has been prepared and characterized by spectroscopic methods and single crystal X-ray analysis. Crystals are monoclinic, space groupP2₁/n, a=28.124(4),b=5.997(1),c=10.434(1)Å, -98.42(1)Å,Z=4. The structure has been refined to a finalR-value of 0.040 for 1625 reflections withF _o>3(F _o). The compound contains the two carbonyl groups in a mutuallycis arrangement.     

Crystal and molecular structures of 5,7-dimethyl-1,8-naphthyridine-2-ol (=LH) and of its mercury (II) complex HgL2 and synthesis of some lanthanide/HgL2 heterometallic complexes

The crystal structures of the title compounds have been determined by single crystal diffraction methods. Crystals of 5,7-dimethyl-1,8-naphthyridine-2-ol (1) are monoclinic, space groupP2₁/n witha=7.336(2),b=8.989(2),c=13.125(3)Å,=95.72(3)°,V=861.2(4)ų,Z=4,D _c =1.34 g cm^–3, finalR=0.052. The molecules are linked in pairs by two N-HO hydrogen bonds, and these dimers are stacked in a discontinuous, stepped fashion. Crystals of HgL₂ (2) are monoclinic space groupP2₁,/c witha=4.044(2),b=12.147(2),c=18.093(5)Å,=93.32(2)°,V=887.3(4)ų,Z=2,D _c =2.05 g cm^–3, finalR=0.051. In2 the mercury binds to N(1) to form a linear N-Hg-N coordination geometry, and the HgL₂ molecules form a continuous stacked structure. The syntheses of the compounds ML₄(NO₃)₃·H₂O (M=Nd, Gd, and Er), PrHg₂L₄(NO₃)₃, andM ₂Hg₃L₆(NO₃)₆ (M=Gd, Er) are also reported.     

Crystal and molecular structure of heptacyclo [9,6,1,14,7,114,17,02,10,03,8,01,13]-eicosa-3(8),5,12,15-tetrene-9, 18-dione

The title compound C₂₀H₁₆O₂ crystallizes in the monoclinic space group P 2₁ witha=6.0310(5)Å,b=13.9396(6)Å,c=8.5560(5)Å, =100.354(8)°,V=770.60(8)ų, andZ=2. The crystal structure has been solved by vector-search methods and refined by fullmatrix least-squares toR=0.05 for 4788 reflections (1>2(1)). The title compound has been prepared in the course of a study on cyclopentanoid natural products.     

Synthesis,nuclear magnetic resonance,and X-ray structural investigations of 1,6-diaza-9,12-dioxacyclotetradeca-2,5-dione

The molecular structure of l,6-diaza-9,12-dioxacyclotetradeca-2,5-dione has been investigated by X-ray and NMR methods. The crystals are monoclinic:C2/c,Z=4,a=8.5571(3),b=14.468(1),c=10.092(2) Å,=113.38(1)°. The structure was solved by direct methods, and refined toR=0.051 on 1082 unique reflections. The molecule exhibits a crystallographic twofold symmetry axis, the axis bisecting the 3C-4C and 10C-11C bonds, which is in full agreement with NMR findings.     

Isolation and crystal structures of triethylenediamine-hydroquinone (1/1) and triethylenediamine-phenol (1/2)

Two crystalline adducts of triethylenediamine with hydroquinone [N(CH₂CH₂)₃N·C₆H₄(OH)₂,I] and phenol [N(CH₂CH₂)₃N·2C₆H₅OH,II] have been isolated and characterized by X-ray analysis. ComplexI crystallizes in the monoclinic space groupC2/c, witha=11.944(2),b=9.491(2),c=11.986(2) Å,=121.70(1)°, andZ=4. Both molecular components occupy sites of symmetry 2, and are linked alternately by N H-O hydrogen bonds to form infinite zigzag chains. Crystals ofII are also monoclinic, with space groupP2₁/c,a=12.987(2),b=6.376(1),c=21.350(3) Å,=106.94(1)°, andZ=4. The structure is composed of discrete hydrogen-bonded molecular aggregates corresponding to the stoichiometric formula. The triethylenediamine moieties in both adducts closely approximate to the idealizedD ₃ h conformation. The structures have been refined toR values of 0.097 (I) and 0.092 (II) using, respectively, 479 and 1580 observed MoK data.     

The structure of a tetrabromotetrahydrodibenzocyclooctene

5, 6, 11, 12-Tetrabromo-5, 6, 11, 12-tetrahydrodibenzo[a, e]cyclooctene, C₁₆H₁₂Br₄, crystallizes in monoclinic space group P2₁/c witha=8.6917(7),b=15.135(2),c=12.892(2) Å, =101.836(8)°, V=1660.0(7) ų,Z=4. The structure was refined toR=0.058 for 3137 observed reflections. The molecule has approximate C₂ symmetry, with the eight-membered ring adopting the twist-boat conformation. The planes of the two phenyl rings form a dihedral angle of 117.3(2)°, C–Br distances range 1.965(5)–1.981(5) Å.     

Crystal structure of 1,3-(N,N′-benzamide)-2-methyl-1-pentene

Crystals of the title compound are monoclinic (C20H22N2O2): space groupP2₁/n,a=11.800(3),b=13.820(2),c=11.004(3) Å,=92.74(3)°. The structure was solved by direct methods and refined by block-matrix least-squares procedure to giveR=0.078 andRw=0.076 for 1960 reflections above 3(I). The two amide groups are not coplanar with respect to their benzene rings. An intramolecular N-HO hydrogen bond was found in the molecules which are joined in chains by other strong N-HO hydrogen bonds.     

Crystal and molecular structure of dihydro-8b,8c-diphenyl-1H,3H,4H,5H,7H,8H,-2,6-dioxa-3a,4a,7a,8a-tetraazacyclopenta[def]fluorene-4,8-dithione

The title compound C₂₀H₁₈N₄O₂S₂ crystallizes in the monoclinic space group P2₁/n witha=8.4930(1) Å,b=11.4880(1) Å,c=20.0709(2) Å, =94.933(1)°,V=1951.01(3) ų,Z=4. The crystal structure has been solved by vector search methods and refined by fullmatrix least-squares toR=0.04 for 2888 reflections and 116 restraints. The title compound has a suitable geometry for synthesizing receptor molecules with a cleft for selective complexation.